TOLVAPTAN vs TORIPALIMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
TOLVAPTAN vs TORIPALIMAB: Safety Overview
| Metric | TOLVAPTAN | TORIPALIMAB |
|---|---|---|
| Total FAERS Reports | 9,014 | 1,344 |
| Deaths Reported | 1,709 | 65 |
| Death Rate | 19.0% | 4.8% |
| Hospitalizations | 2,467 | 823 |
| Average Patient Age | 56.2 yrs | 58.0 yrs |
| % Female Patients | 52.0% | 24.9% |
| FDA Approval Date | Apr 23, 2018 | N/A |
| Manufacturer | Otsuka America Pharmaceutical, Inc. | Coherus Oncology, Inc. |
| Route | ORAL | INTRAVENOUS |
| Marketing Status | Prescription | N/A |